EyePoint Cuts 53% of Staff, Ends Wet AMD Trials After Second Phase 3 Failure
EYPT is trading near its 52-week low of $2.93 (81% below the low).
Summary
After LUCIA became the second Phase 3 wet AMD failure, EyePoint is cutting about 53% of its workforce, ending the wet AMD trials early and focusing entirely on DURAVYU in DME, with pivotal data now expected in Q4 2027.
Key Events · Product Development and Regulatory · EYPT
-
Wet AMD Program Abandoned
After LUCIA missed its primary non-inferiority endpoint, the board approved concluding the pivotal Phase 3 wet AMD trials early, without completing the second year.
-
53% Workforce Reduction
About 53% of positions are being eliminated, mostly in Q4 2026 and completed in H1 2027, at an estimated $9 million in separation charges, substantially all cash.
-
About $30M Annualized Savings
The prioritization is expected to generate roughly $30 million of annualized savings, aimed at preserving capital for the DME program.
-
About $118M Cash at September 30
Preliminary, unreviewed cash, cash equivalents and short-term investments of approximately $118 million as of September 30, 2026.
Analysis · EYPT · Industrial Applications And Services
With both wet AMD Phase 3 trials now failed, EyePoint is abandoning the larger indication and betting the company on DURAVYU in DME, where pivotal data are not due until Q4 2027. What keeps the roughly $118 million of cash as of September 30, 2026 stretching toward that readout is the 53% workforce cut and roughly $30 million in annualized savings. Yet a single remaining program with a two-year gap to data leaves little margin for error, and the roughly $9 million of severance charges are largely cash. The stock is already near its 52-week low, reflecting how much of the prior valuation depended on wet AMD.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 43.2% of the 271 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EYPT was trading at $0.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $257.8M. The 52-week trading range was $2.93 to $19.11. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.